Reuters logo
BRIEF-Pacira Pharmaceuticals announces proposed offering of $300 million aggregate principal amount of convertible senior notes
March 6, 2017 / 9:13 PM / 8 months ago

BRIEF-Pacira Pharmaceuticals announces proposed offering of $300 million aggregate principal amount of convertible senior notes

March 6 (Reuters) - Pacira Pharmaceuticals Inc

* Announces proposed offering of $300 million aggregate principal amount of convertible senior notes

* Announced it intends to offer $300 million aggregate principal amount of convertible senior notes due 2022

* Intends to use portion of net proceeds to enter into agreements with certain holders of 3.25 pct convertible senior notes due 2019 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below